Serina Therapeutics (SER) Divestments (2018 - 2021)

Serina Therapeutics (SER) posted Divestments of -$50000.0 for Q1 2021, down 164.94% sequentially from $77000.0 in Q3 2019.

Serina Therapeutics (SER) Divestments (2018 - 2021) Analysis & Trends

Serina Therapeutics has reported Divestments for 3 years, with the latest figure at -$50000.0 in Q1 2021.

Quarterly Divestments changed N/A year-over-year to -$50000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$50000.0 (changed N/A YoY) and the FY2021 annual result came in at -$50000.0, changed N/A from the prior year.
Divestments eased to -$50000.0 in Q1 2021 per SER's latest filing, from $77000.0 in the prior quarter.
Over five years, Divestments peaked at $3.2 million in Q1 2018 and troughed at -$50000.0 in Q1 2021.
A 3-year average of $1.1 million and a median of $77000.0 in 2019 frame the typical range for Divestments.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Vertex Pharmaceuticals	138.41 Bn	130.56 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn	-
3	Argenx Se	64.41 Bn	59.23 Bn	1.37 Bn	-
4	Moderna	57.56 Bn	52.43 Bn	52.00 Mn	-
5	BeOne Medicines	42.06 Bn	36.96 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.95 Bn	27.65 Bn	992.69 Mn	-
7	BioNTech SE	27.48 Bn	9.09 Bn	668.28 Mn	-
8	Insmed	27.31 Bn	26.15 Bn	358.27 Mn	-
9	Royalty Pharma	27.04 Bn	26.20 Bn	-	-13.21 Mn
10	Serina Therapeutics	45.39 Mn	22.36 Mn	-	-

Download Data